Total body calcium measurements using neutron-activation analysis in Cushing's syndrome

Total body calcium content (TBCa) was estimated by in vivo neutron activation analysis in 16 patients (14 female, 2 male) with active Cushing's syndrome, pituitary driven in all but two cases. Apart from being nonreproductive, patients were unselected. TBCa was below the predicted young normal...

Full description

Saved in:
Bibliographic Details
Published in:Calcified tissue international 1986-09, Vol.39 (3), p.145-150
Main Authors: Williams, G, Spinks, T J, Freemantle, C, Sandler, L, Joplin, G F
Format: Article
Language:English
Subjects:
Adrenalectomy
Adult
Aged
Brachytherapy
Calcium - analysis
Cushing Syndrome - metabolism
Cushing Syndrome - therapy
Female
Humans
Hydrocortisone - urine
Male
Middle Aged
Neutron Activation Analysis
Thyroxine - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Total body calcium content (TBCa) was estimated by in vivo neutron activation analysis in 16 patients (14 female, 2 male) with active Cushing's syndrome, pituitary driven in all but two cases. Apart from being nonreproductive, patients were unselected. TBCa was below the predicted young normal value in all patients (mean +/- SD, 85.2 +/- 5.8% of predicted, P less than 0.01 vs. predicted) and in 13 of the 16 patients, was also below the predicted value when allowance was made for expected postmenopausal skeletal losses (mean +/- SD, 92.7 +/- 12.5% of predicted, P less than 0.02). However, individual values of TBCa were significantly lower (P less than or equal to 0.05) than the predicted normal range, corrected for postmenopausal losses, in only 3 patients (19% of the group). Initial TBCa apparently was not related to duration of the disease or to current urinary-free cortisol levels. At presentation, radiographic signs of significant osteoporosis (multiple vertebral and/or rib fractures) were present in four patients, three of whom had subnormal or borderline TBCa compared with the young normal predicted range. TBCa measurements were repeated in 9 patients 1-10 years after successful treatment, and were generally unchanged. During this period, only one vertebral fracture (consistent with simple postmenopausal osteoporosis) appeared in these patients. We conclude that bone mass tends to be low in newly diagnosed Cushing's syndrome, but that significant reduction beyond expected postmenopausal losses is relatively uncommon.
ISSN:0171-967X
1432-0827
DOI:10.1007/BF02555110